Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1983 3
1984 1
1987 1
1988 1
1989 1
1991 3
1992 1
1993 2
1994 1
1995 1
1996 1
1998 4
1999 9
2000 3
2001 7
2002 15
2003 9
2004 22
2005 16
2006 31
2007 44
2008 73
2009 88
2010 99
2011 81
2012 103
2013 119
2014 100
2015 122
2016 156
2017 166
2018 199
2019 255
2020 293
2021 340
2022 404
2023 301
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

2,733 results

Results by year

Filters applied: . Clear all
Page 1
Can EGFR be a therapeutic target in breast cancer?
Li X, Zhao L, Chen C, Nie J, Jiao B. Li X, et al. Among authors: nie j. Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188789. doi: 10.1016/j.bbcan.2022.188789. Epub 2022 Sep 3. Biochim Biophys Acta Rev Cancer. 2022. PMID: 36064121 Review.
Pseudotyped Viruses.
Wang Y, Zhou Z, Wu X, Li T, Wu J, Cai M, Nie J, Wang W, Cui Z. Wang Y, et al. Among authors: nie j. Adv Exp Med Biol. 2023;1407:1-27. doi: 10.1007/978-981-99-0113-5_1. Adv Exp Med Biol. 2023. PMID: 36920689
AUTHOR REPLY.
Nie J, Leapman MS. Nie J, et al. Urology. 2022 Sep;167:127. doi: 10.1016/j.urology.2022.03.047. Urology. 2022. PMID: 36153094 No abstract available.
AUTHOR REPLY.
Nie J, Breyer BN, Leapman MS. Nie J, et al. Urology. 2022 Jun;164:117. doi: 10.1016/j.urology.2022.01.060. Urology. 2022. PMID: 35710166 No abstract available.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: nie jh. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
2,733 results